Bactericidal effect of sparfloxacin alone and in combination with amoxicillin against Streptococcus pneumoniae as determined by kill-kinetic studies

被引:1
作者
Barakett, V
Lesage, D
Delisle, F
Richard, G
Petit, JC
机构
[1] Lab. de Bacteriol.-Virologie, Hôpital St. Antoine, F-75571 Paris Cedex 12
关键词
D O I
10.1007/BF01780645
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Ten clinical isolates of Streptococcus pneumoniae (six intermediately penicillin-sensitive, one penicillin-resistant and three penicillin-sensitive strains) were studied by kill-kinetic experiments using sparfloxacin alone and in combination with amoxicillin. Equipotent doses of the antibiotics (1x, 2x and 4x the MIC) were used in the kill-kinetic studies. Sparfloxacin had a moderate bactericidal potential at 4x: MIC after 5 h and the combination with amoxicillin did not significantly increase its bactericidal activity. The clinical significance of these findings warrants further studies in vivo.
引用
收藏
页码:22 / 25
页数:4
相关论文
共 17 条
[1]   SUSCEPTIBILITY OF PENICILLIN-SENSITIVE AND PENICILLIN-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE TO NEW ANTIMICROBIAL AGENTS, INCLUDING DAPTOMYCIN, TEICOPLANIN, CEFPODOXIME AND QUINOLONES [J].
APPELBAUM, PC ;
SPANGLER, SK ;
CROTTY, E ;
JACOBS, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (04) :509-516
[2]  
AUBIER M, 1993, 33 INT C ANT AG CHEM
[3]   INVIVO EFFICACY OF A NEW FLUOROQUINOLONE, SPARFLOXACIN, AGAINST PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT AND MULTIRESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE IN A MOUSE MODEL OF PNEUMONIA [J].
AZOULAYDUPUIS, E ;
VALLEE, E ;
VEBER, B ;
BEDOS, JP ;
BAUCHET, J ;
POCIDALO, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2698-2703
[4]   A REVIEW OF ANTIBIOTIC-RESISTANCE PATTERNS OF STREPTOCOCCUS-PNEUMONIAE IN EUROPE [J].
BAQUERO, F ;
MARTINEZBELTRAN, J ;
LOZA, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :31-38
[5]   CLINICAL OUTCOME OF ACUTE OTITIS-MEDIA CAUSED BY PNEUMOCOCCI WITH DECREASED SUSCEPTIBILITY TO PENICILLIN [J].
BARRY, B ;
GEHANNO, P ;
BLUMEN, M ;
BOUCOT, I .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (04) :446-452
[6]   INVITRO ACTIVITY OF SPARFLOXACIN COMPARED WITH THOSE OF 5 OTHER QUINOLONES [J].
CANTON, E ;
PEMAN, J ;
JIMENEZ, MT ;
RAMON, MS ;
GOBERNADO, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :558-565
[7]   EFFICACY AND SAFETY OF TEMAFLOXACIN VERSUS THOSE OF AMOXICILLIN IN HOSPITALIZED ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA [J].
CARBON, C ;
LEOPHONTE, P ;
PETITPRETZ, P ;
CHAUVIN, JP ;
HAZEBROUCQ, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :833-839
[8]  
GARAU J, 1993, 33 INT C ANT AG CHEM
[9]   TREATMENT AND DIAGNOSIS OF INFECTIONS CAUSED BY DRUG-RESISTANT STREPTOCOCCUS-PNEUMONIAE [J].
JACOBS, MR .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :119-127
[10]   EMERGENCE OF MULTIPLY RESISTANT PNEUMOCOCCI [J].
JACOBS, MR ;
KOORNHOF, HJ ;
ROBINSBROWNE, RM ;
STEVENSON, CM ;
VERMAAK, ZA ;
FREIMAN, I ;
MILLER, GB ;
WITCOMB, MA ;
ISAACSON, M ;
WARD, JI ;
AUSTRIAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (14) :735-740